Investing.com - Evotec SE ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Evotec SE ADR announced earnings per share of $0.06 on revenue of $177.27M. Analysts polled by Investing.com anticipated EPS of $0.21 on revenue of $188.75M.
Evotec SE ADR shares are up 86.39% from the beginning of the year and are trading at $8.54 , down-from-52-week-high.
Evotec SE ADR follows other major Healthcare sector earnings this month
Evotec SE ADR's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar